Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04260802 |
| Title | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Ocellaris Pharma, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cross Cancer Institute | RECRUITING | Edmonton | Alberta | T6G 1Z2 | Canada | Details |
| Ottawa Hospital Cancer Centre (OHRI) | RECRUITING | Ottawa | Ontario | Canada | Details | |
| Princess Margaret Hospital | RECRUITING | Toronto | Ontario | M5G 2C1 | Canada | Details |
| Jewish General Hospital - Clinical Research Unit | RECRUITING | Montreal | Quebec | H3T 1E2 | Canada | Details |
| Centre hospitalier de l'Université de Montréal (CHUM) | RECRUITING | Montréal | Quebec | H2X 0A9 | Canada | Details |